Presentation CDM 2017 Can CHD and DM be Prevented? The Answer is on Your Plate Presenter: Robert A. Vogel October 05, 2017
News Daily News Vast Majority Return to Work After MI, but It Doesn’t Always Stick Todd Neale October 04, 2017
News Industry News Geisinger and Boehringer Ingelheim collaborate to create a predictive model to help improve health outcomes for people with type 2 diabetes at greatest risk of serious long-term complications, including cardiovascular death October 02, 2017
News Daily News Quitting Chronic, Low-Dose Aspirin May Boost Risk of Cardiovascular Events Todd Neale September 25, 2017
News Daily News Secondary Prevention Lagging Behind in Women With Established Coronary Disease Todd Neale September 22, 2017
News Daily News Study Questions Incremental Benefit of Beta-Blockers After Acute MI Michael O'Riordan September 21, 2017
News Daily News Ischemic Heart Disease the Leading Cause of Death Globally Michael O'Riordan September 19, 2017
Presentation Global Geographic Variation in Patient Characteristics in PCI Clinical Trials September 15, 2017
News Industry News New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes September 15, 2017
News Daily News Patients in PCI Trials Vary Around the World, With Women Still Underrepresented Michael O'Riordan September 15, 2017
News Daily News Hormone Therapy Doesn’t Impact Long-term All-Cause, CV, or Cancer Mortality: WHI Analysis Caitlin E. Cox September 14, 2017
News Conference News VIVA 2017 DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease L.A. McKeown September 13, 2017
News Industry News Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials September 12, 2017
News Conference News ESC 2017 ESC Releases Revamped DAPT Guidance Focusing on Personalized Approach Todd Neale September 01, 2017
News Conference News ESC 2017 Women at High Cardiovascular Risk Unlikely to Get to Low LDL Targets Michael O'Riordan August 30, 2017
News Conference News ESC 2017 Anacetrapib Finds (Modest) Success Where All Other CETP Inhibitors Failed Michael O'Riordan August 29, 2017
Presentation ESC 2017 PCI vs CABG in Patients with Type 1 Diabetes and Multivessel Disease Presenter: Martin J. Holzmann August 28, 2017
News Conference News ESC 2017 VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost? Shelley Wood August 28, 2017